After COVID-19: Lung Cancer Screening and Treatment

This expert panel focuses in on the significance of lung cancer screening and treatment approaches following the COVID-19 pandemic.

EP. 1: Introducing the Post-Pandemic Change With Lung Cancer Screening

July 8th 2021

Albert Rizzo, MD, FCCP FACP FAASM, chief medical officer of the American Lung Association, as well as clinical assistant professor of medicine at Sidney Kimmel Medical College, Thomas Jefferson University, moderates the webinar Lung Cancer Screening & Treatment After COVID-19.

EP. 2: Opportunities and Challenges With Lung Cancer Screening Following COVID-19

July 8th 2021

James L. Mulshine, MD, professor of internal medicine, as well as associate director of the Institute of Translation Medicine at Rush University, shared some of the challenges that have stemmed from the COVID-19 pandemic and how it has impacted lung cancer screening in the United States.

EP. 3: How to Reduce Lung Cancer Screening Disparities After COVID-19

July 8th 2021

Andrea Borondy Kitts, Lung Cancer and Patient Advocate at Rescue Lung Society, provides the perspective of a patient with lung cancer on the gaps in lung cancer care that are driven by screening disparities. She also gives insight and the events of COVID-19 did to influence that issue.

EP. 4: The Effects of COVID-19 and Vaccinations in Non–Small Cell Lung Cancer

July 8th 2021

Sandip Patel, MD, an associate professor of medical oncology at University of California San Diego, explains the two-fold effects of how COVID-19 has impacted patients with non–small cell lung cancer, including their eligibility for the available vaccines designed to protect against the virus.

EP. 5: Therapeutic Approaches in Small Cell Lung Cancer

July 8th 2021

Jacob Sands, MD, a physician at Dana-Farber Cancer Institute, as well as instructor of medicine at Harvard Medical School, provides a comprehensive review of the small cell lung cancer treatment paradigm, and how COVID-19 has limited treatment opportunities and continuation in patients.

EP. 6: 2021 USPSTF Lung Cancer Screening Recommendations

July 8th 2021

M. Patricia Rivera, MD, professor of medicine at the University of North Carolina at Chapel Hill, shares a review of the United States Preventive Services Task Force 2021's lung cancer screening recommendations, which feature impacted patient populations and effects they have on direct physician care.

EP. 7: Concluding Remarks in Lung Cancer Screening Following COVID-19

July 8th 2021

The 6-person panel concludes the discussion on lung cancer screening following the COVID-19 pandemic with an interactive question and answer session revolving around shared decision making, nonsmoker patient screening options, and molecular testing via standard tissue.